A Method to Evaluate Fetal Erythropoiesis from Postnatal Survival of Fetal RBCs
Denison J Kuruvilla1, John A Widness, Demet Nalbant
1Department of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa, 115 S. Grand Ave. S227, Iowa City, Iowa, 52242, USA.
Insights
This study introduces a novel mathematical model to analyze fetal red blood cell (RBC) production and lifespan in preterm infants using postnatal survival data. The model offers insights into in utero erythropoiesis and RBC lifespan changes during gestation.
Area of Science:
- Neonatal Medicine
- Hematology
- Mathematical Biology
Background:
- Fetal red blood cells (RBCs) have shorter lifespans than adult RBCs and are produced under hypoxic conditions.
- Evaluating fetal erythropoiesis in utero is challenging due to the non-steady-state nature of production and varying RBC lifespans.
Purpose of the Study:
- To develop and validate a novel mathematical model for assessing non-steady-state fetal erythropoiesis and RBC lifespan using postnatal survival data.
- To investigate the impact of erythropoiesis rate, RBC lifespan changes, and phlebotomy on RBC survival curves.
Main Methods:
- A mathematical model was developed to analyze in vivo RBC survival data collected within 2 days after birth.
- The model accounts for dynamic changes in erythropoiesis rate and RBC lifespan, as well as the effects of multiple phlebotomies.
- The model was applied to biotin-labeled RBC survival curves from ten anemic, very low birth weight preterm infants.
Main Results:
- The model successfully estimated mean fetal RBC production rate (1.07 × 10^7 RBCs/day/g) and mean RBC lifespan at birth (52.1 days).
- In utero RBC lifespan was found to increase by 0.51 days per day of gestation.
- Model simulations confirmed its ability to differentiate effects of erythropoiesis, lifespan changes, and phlebotomy on RBC survival.
Conclusions:
- The proposed mathematical model provides a flexible framework for studying in utero non-steady-state fetal erythropoiesis in newborn infants.
- This method allows for retrospective analysis of fetal RBC production and lifespan dynamics.
Abstract:
Fetal RBCs are produced during a period of very rapid growth and stimulated erythropoiesis under hypoxic intrauterine conditions. Fetal RBC life span varies with gestational age (GA) and is shorter than that in healthy adults. Due to the special kinetic properties of life span-based survival of human RBCs, a mathematical model-based kinetic analysis of the survival of fetal RBCs shortly after birth provides a unique opportunity to "look backward in time" to evaluate fetal erythropoiesis. This work introduces a novel method that utilizes postnatal in vivo RBC survival data collected within 2 days after birth to study both nonsteady-state (non-SS) in utero RBC production and changing fetal RBC life span over time. The effect of changes in erythropoiesis rate and RBC life span and the effect of multiple postnatal phlebotomies on the RBC survival curves were investigated using model-based simulations. This mathematical model, which considers both changes in the rate of erythropoiesis and RBC life span and which accurately accounts for the confounding effect of multiple phlebotomies, was applied to survival curves for biotin-labeled RBCs from ten anemic very low birth weight preterm infants. The estimated mean fetal RBC production rate scaled by body weight was 1.07 × 10(7) RBCs/day g, and the mean RBC life span at birth was 52.1 days; these values are consistent with reported values. The in utero RBC life span increased at a rate of 0.51 days per day of gestation. We conclude that the proposed mathematical model and its implementation provide a flexible framework to study in utero non-SS fetal erythropoiesis in newborn infants.
More Related Videos
06:40Mouse Fetal Liver Culture System to Dissect Target Gene Functions at the Early and Late Stages of Terminal Erythropoiesis
Published on: September 9, 2014
15:32Identification and Analysis of Mouse Erythroid Progenitors using the CD71/TER119 Flow-cytometric Assay
Published on: August 5, 2011
